Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.945 USD | +0.25% | -12.13% | -29.95% |
16/05 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
08/04 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.95% | 364M | |
+60.25% | 62.59B | |
-2.90% | 41.18B | |
+44.53% | 40.29B | |
-8.29% | 27.9B | |
+12.49% | 26.21B | |
-21.62% | 19.09B | |
+5.86% | 13.08B | |
+24.54% | 12.26B | |
+27.06% | 12.05B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Replimune Group's Fiscal Q4 Net Loss Widens